IDEAYA Biosciences (IDYA) Non Operating Income (2018 - 2026)

IDEAYA Biosciences has disclosed Non Operating Income across 9 years of filings, most recently posting $10.0 million for Q1 2026.

• Non Operating Income for Q1 2026 came in at $10.0 million, down 18.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $43.4 million (down 18.5% YoY), and the FY2025 annual result was $45.6 million, down 13.11% from the prior year.
• Non Operating Income came in at $10.0 million for Q1 2026 at IDEAYA Biosciences, down from $11.3 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $15.1 million in Q3 2024 to a low of $207000.0 in Q1 2022.
• The 5-year median for Non Operating Income is $10.0 million (2026), against an average of $7.8 million.
• Across the five-year window, Non Operating Income surged 1328.03% in 2022 and fell 28.4% in 2025, its largest moves.
• IDEAYA Biosciences' Non Operating Income stood at $2.2 million in 2022, then soared by 255.13% to $8.0 million in 2023, then soared by 73.65% to $13.8 million in 2024, then slipped by 18.29% to $11.3 million in 2025, then dropped by 11.44% to $10.0 million in 2026.
• The last three Non Operating Income figures came in at $10.0 million (Q1 2026), $11.3 million (Q4 2025), and $10.8 million (Q3 2025), per Business Quant data.